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Abstract
Background: Inconclusive evidence has suggested a possible link between air pollution and central nervous
system (CNS) tumors. We investigated a range of air pollutants in relation to types of CNS tumors.
Methods: We identified all (n = 21,057) intracranial tumors in brain, meninges and cranial nerves diagnosed in
Denmark between 1989 and 2014 and matched controls on age, sex and year of birth. We established personal 10-
year mean residential outdoor exposure to particulate matter < 2.5 μm (PM2.5), nitrous oxides (NOX), primary emitted
black carbon (BC) and ozone. We used conditional logistic regression to calculate odds ratios (OR) linearly (per
interquartile range (IQR)) and categorically. We accounted for personal income, employment, marital status, use of
medication as well as socio-demographic conditions at area level.
Results: Malignant tumors of the intracranial CNS was associated with BC (OR: 1.034, 95%CI: 1.005–1.065 per IQR.
For NOx the OR per IQR was 1.026 (95%CI: 0.998–1.056). For malignant non-glioma tumors of the brain we found
associations with PM2.5 (OR: 1.267, 95%CI: 1.053–1.524 per IQR), BC (OR: 1.049, 95%CI: 0.996–1.106) and NOx (OR:
1.051, 95% CI: 0.996–1.110).
Conclusion: Our results suggest that air pollution is associated with malignant intracranial CNS tumors and
malignant non-glioma of the brain. However, additional studies are needed.
Keywords: Epidemiology, Air pollution, Register study, CNS-tumors
Background
Intracranial tumors of the central nervous system (CNS)
are a heterogeneous group of tumors of primarily the
meninges, the cranial nerves and the brain. Benign tu-
mors are most often located in the meninges, and glioma
is the most common malignant tumor type. The inci-
dence of intracranial CNS tumor types differ by age, sex
and race [1, 2]. Around 5% of these tumors are attribut-
able to a range of hereditary syndromes [1]. While the
only established exogenous risk factor is ionizing radi-
ation, mounting evidence points toward a protective as-
sociation with allergic and atopic conditions [1, 3, 4]. A
range of medications has been investigated for potential
associations [5–7] and some studies have suggested a
link with exposures to pesticides or fertilizers [8–11],
but the results are inconclusive. At present, no occupa-
tional or environmental risk factors for CNS tumors
have been conclusively established [2, 12]. One candi-
date is, however, air pollution, which has been classified
as “carcinogenic to humans” by the International Agency
for Research on Cancer [13, 14] based primarily on
mechanistic studies and epidemiological research
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demonstrating associations with lung cancer. Studies
have indicated that ultrafine particles may reach the
brain via the olfactory nerve or by crossing from the
lungs to the blood stream and then passing the blood-
brain barrier [15, 16]. Air pollution exposures have been
associated with stroke and negative cognitive effects
[17–20] and neuroimaging has shown links with reduced
total brain and brain white matter volume [21].
Ambient air pollution consists of a complex array of
substances that may be mutagenic/carcinogenic either
directly or indirectly via induced inflammation and oxi-
dative stress [16, 22]. As ultrafine particles (UFP) may
reach the brain and due to their large number, small size
and large surface area, scientific focus with regard to
brain tumors has been on UFP and in a recent cohort
study from Canada UFP exposure level was associated
with risk of malignant brain tumors [23]. However, con-
centrations of airborne UFP are difficult to model. In
Denmark, nitrogen oxides show good temporal correl-
ation with UFP in street canyons [24, 25] and has,been
used in epidemiological studies [26–28].
Several studies have investigated air pollution in rela-
tion to brain tumors with inconsistent results. An eco-
logical study from the US found volatile organic
compounds to be associated with county-level incidence
of tumors of the CNS [29]. Two studies of a cohort from
the US found no association between a range of air pol-
lutants (particulate matter with a diameter less than
2.5 μm (PM2.5) and 10 μm (PM10), sulphur dioxide, ni-
trogen dioxide, carbon monoxide or ozone (O3)) and
mortality from malignant tumors of the brain [30, 31].
In an exploratory analysis of 54,304 members of the Da-
nish Diet Cancer and Health cohort, mean outdoor resi-
dential NOx levels since 1971 were associated with an
incidence rate ratio of 2.28 (95% confidence interval
(CI): 1.25–4.19, cases = 95) per 100 μg/m3 increase, for
tumors of the brain and central nervous system [26]. In
a nationwide Danish study of 4183 cases diagnosed over
the years 2000–2009, the odds ratio (OR) for a tumor
(benign or malignant) of the brain was 1.11 (95% 0.84–
1.4) per 100 μg/m3 increase in NOx and the correspond-
ing OR for non-glioma tumors of the brain was 1.53
(95% CI 1.02–2.29) [32]. The study indicated that
increased brain tumor risk may only be detectable at
high NOx levels (> 80 μg/m
3). The Danish Nurses Health
Cohort study investigated intracranial CNS tumors (n =
121) and reported suggestions of a weak association with
mean outdoor concentrations of particulate matter <
2.5 μm, PM < 10 μm, NO2 and NOx over past 3 years.
Restricting the analysis to meningioma or benign tumors
increased risk estimates, but still with wide confidence
intervals spanning the null [33]. The same tumor end-
points were investigated in the ESCAPE project that
combined cohorts from six European countries, which
found a suggestive evidence of an association between
malignant tumors and long-term exposure to PM2.5 ab-
sorbance, a quantity closely related to elemental carbon
and proposed by the authors to be a proxy for traffic re-
lated UFP [34].
In summary, some studies have found indications of
an association between one or more air pollutants and
one or more tumor types, however, the results are in-
consistent. Possible explanations may relate to the rela-
tively low number of cases but also to differences in
tumor definitions, exposure assessment and the covari-
ates adjusted for. We, therefore, conducted a large
register-based case-control study of all intracranial CNS
tumors, diagnosed in Denmark over the years 1989 to
2014 with an aim to investigate the different subtypes of
tumors in relation to a range of air pollutants from a
state-of-the-art exposure model.
Materials and methods
The study was conducted in Denmark (population dur-
ing the study period, approx. 5.4 million), were all
citizens since 1968 have had a unique personal identifi-
cation number, which allows individuals to be identified
and tracked across all health and administrative registers
in Denmark [35, 36].
Case ascertainment
From the Danish Cancer Register, which holds nearly
complete records of all cancer diagnoses in Denmark
since 1943 [37, 38], we identified all Danes, aged 20 years
or above, with a primary intracranial tumor (i.e. a tumor
of the meninges, the cranial nerves, or the brain) in the
period 1989 to 2014 Cases were not allowed to have
other cancer diagnoses, except non-melanoma skin can-
cer, prior to their brain tumor.
Sampling of controls
For each case we sampled two random controls, alive
and without a cancer diagnosis at the date of diagnosis
for their matched case (index-date), from the Danish
Civil Registration System [39]. Controls were matched
on sex and birth year and month.
Exclusion criteria
Cases and controls were excluded if they had: 1) No re-
corded address in Denmark (excluding Greenland and
the Faroe Islands) at index-date. 2) Less than 80% geo-
codable address history for the ten-year period preceding
index-date. 3) Missing information on marital status,
employment status, household disposable income or area
of residence (parish). Information for some of these ex-
clusions was available only after initial matching. There-
fore, cases ending without controls or vice versa after
full matching and exclusions were excluded.
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Exposure assessment
We extracted address histories for all cases and controls
since 1979 from the Danish Civil Registration System
[39] since air pollution modeling was possible from this
year onwards. We geocoded all addresses, and front door
air-pollutant concentrations at 2 m height were esti-
mated for each of these addresses using the Danish
DEHM/UBM/AirGIS modelling system [40, 41]. This in-
tegrated air pollution model system incorporates detailed
time-varying information based on three air pollution
contributions: 1) regional background, modelled with
the DEHM model [42] on 150 km × 150 km scale cover-
ing the northern hemisphere and increasing resolution
towards a 5.6 km × 5.6 km scale over Denmark, based on
historical international and national emission data (in-
cluding natural emissions); 2) urban background mod-
elled with the UBM model [43] on 1 km × 1 km scale,
based on high resolution emission data for Denmark for
all emission sectors, land-use data and building heights;
and 3) address-level local air pollution calculated with
the OSPM model [44], based on street-level data on traf-
fic type and intensity combined with emission factors
and taking into account meteorology as well as street
and building configuration. The model system is de-
scribed in detail elsewhere [45, 46]. The model system
provided yearly mean values of PM2.5, black carbon (BC
– (a primary component of particulate matter), as well
as the gases: O3, and NOx. The level of the latter corre-
lates well with ultrafine particulate matter and has previ-
ously been utilized as a proxy for these [26–28] .
For each individual, we calculated a time-weighted
average (TWA) concentration over residential addresses
during the 10 years preceding the index-date.
Covariates
From Statistics Denmark, we obtained yearly individual-
level information on disposable income, marital status,
employment status and country of origin. For all Danish
parishes we obtained yearly information on percentage
of the adult population: in lowest income quartile, un-
employed, retired, doing manual labor, owning their
own dwelling, living in social housing, being of Danish
origin, previously convicted (theft, robbery, vandalism or
violence), single parent families and having basic educa-
tion as highest attained education level. In 1996, a total
of 2160 parishes existed with a median number of 1032
inhabitants (range 33–35,979) and a mean area of 16.2
km2 (range 0.1–126.2). From the Danish National Pre-
scription Register, which holds information on all pre-
scription drugs redeemed in Denmark since 1995 [47],
we obtained information on prescriptions for asthma or
allergy conditions (ATC: R03, R06A) [47], prescriptions
for hormone replacement therapy (HRT) (ATC: G03C,
G03D, G03F, G03HB01), NSAIDs (ATC: B01AC06,
B01AC30, N02BA01, N02BA51), non-aspirin NSAID
(ATC: M01A except: M01AX), and antidiabetics (ATC:
A10A, A10B). We identified all subjects who within a
year redeemed at least two separate prescriptions for
each drug to increase the likelihood that they were actu-
ally using the drug (NSAIDs and HRT) and/or that the
indication was diabetes, asthma or allergy.
Statistical methods
We used conditional logistic regression to calculate ORs
for all intracranial CNS tumors (International Classifica-
tion of Diseases, version 10 (ICD10): C70.0, C71.0-C71.9,
C72.2, C72.5, D32.0,D33.0-D33.3,D42.0,D43.0-D43.3) and
for the following subgroups: malignant tumors (prefix C),
non-malignant tumors (prefix D), cranial nerves (C72.2,
C72.5,D33.3,D43.3), meningioma (C70.0,D32.0,D42.0), gli-
oma (morphology codes 9380/0–9480/9 within ICD10:
C71.0-C71.9, D33.0-D33.3, D43.0-D43.2), malignant non-
glioma brain tumors (all other morphologies within
ICD10: C71.0-C71.9) and non-malignant non-glioma
brain tumors (all other morphologies within ICD10:
D33.0-D33.3, D43.0-D43.2). All pollutants were analyzed
categorically as well as linearly since previous studies had
suggested that effects may only be apparent among the
highly exposed. In the categorical analyses, we used cat-
egories based on percentiles of exposure among controls:
<50th percentile (reference), 50-94th percentile, 95-99th
percentile and > 99th percentile. These categories pro-
vided a separate risk estimate for the few people with very
high exposure, since a previous study found associations
only in this group [32]. For all linear analyses, we tested
for deviations from linearity by likelihood ratio testing
comparing our model with a model including also the
second-degree polynomial of the pollutant and with a
model dividing the pollutant in 20 equal sized groups. We
found no consistent signs of deviations (Supplement
Table 1).
We analyzed data in three models: a crude model, only
taking into account the matching factors; a model add-
itionally adjusting for individual-level covariates, and a
final, main model, which also included parish-level co-
variates. Individual-level covariates included personal in-
come in deciles (calculated annually based on the
distribution among controls), marital status (currently
living together, formerly married or never married) and
employment status (retired, unemployed, blue collar,
low-level white collar, high-level white collar). The main,
final model also included percentages of adult parish
population in the lowest income quartile, unemployed,
retired, doing manual labor, owning their own dwelling,
living in social housing, being of Danish origin, previ-
ously convicted of a crime, single parent families and
having basic education as highest attained education
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level. To minimize potential effects of prodromal symp-
toms, we assessed covariates 1 year before index-date.
We also conducted sensitivity analyses using the TWA
exposure over 1 year and over 5 years. Finally, in an
analysis restricting to cases diagnosed after 1995, we ad-
justed for ever-use of HRT [1, 6] NSAID and non-
aspirin NSAID [5], which some studies have associated
with CNS tumors and Danish administrative data sug-
gest higher usage in more urbanized regions. We also
adjusted for use of antidiabetics, and medication for
asthma or allergy conditions since studies have sug-
gested that both diabetes and allergy could be associ-
ated with a decreased risk for types of CNS tumors
and some studies also associate these conditions with
air pollution [48, 49].
Statistical analysis was performed in SAS 9.3 (SAS In-
stitute Inc., Cary, NC, USA).
Results
We identified 22,454 adult cases diagnosed with a
primary intracranial CNS tumor in the period 1989 to
2014 and 44,908 matched controls. We excluded cases
(45 / 0.2%) and controls (3567 / 7.9%) not living in
Denmark at the time of diagnosis, as well as cases (865 /
3.9%) and controls (2318 / 5.2%) who had less than 80%
geocodable address history in Denmark for the period
10 years before index-date. We also excluded 42 cases
(0.2%) and 126 controls (0.3%) due to missing data on
one or more covariates. Finally, we excluded 445 cases
(2.0%) with no remaining controls and 1529 controls
(3.4%) with no case, after the above exclusions. The
resulting population comprised 21,057 cases and 37,368
controls. Of these cases, 7465 were glioma and 5657
were meningioma. Malignant tumors comprised 46% of
the cases.
Table 1 shows virtually no differences between cases
and controls for any covariate. Similarly, Table 2 shows
similar distributions of the air pollutants for cases and
controls below the 99th percentile. However, the max-
imum observed concentrations of BC, PM2.5 NO2 and
NOx were higher among cases. The correlation coeffi-
cients between air pollutants were in the range between
− 0.98 and 0.94 (Table 3).
In linear analysis, the ORs for association with total
intracranial CNS tumors was 0.967 (95%CI: 0.934–
1.002) for O3, 1.011 (95%CI: 0.992–1.030) for NOx 1.031
(95%ci: 0.997–1.066) for NO2 and 1.016 (95%CI: 0.996–
1.037) for BC. For BC, the categorical results showed an
exposure response pattern.
Malignant tumors of the intracranial CNS was associ-
ated with BC (OR: 1.034, 95%CI: 1.005–1.065 per IQR),
NO2 (OR: 1.042, 95%CI: 0.992–1.095 per IQR) and NOx
(OR: 1.026, 95%CI: 0.998–1.056 per IQR). Except for
Table 1 Descriptive characteristics of intracranial CNS tumor
cases and matched controls. Denmark, 1989–2014
CASES CONTROLS
TOTAL 21,057 37,368
Individual level factors:
FEMALE 53% 54%
Age at index datea
median 62 63
10th pctl 39 39
90th pctl 80 80
Region of origin 0
Denmark 96% 95%
Non-Western 2% 2%
Western 3% 3%
Marital status
Living together 61% 59%
Previously married 25% 26%
Never married 14% 14%
Occupational status
Unemployed 4% 4%
Low skill level 23% 22%
Medium skill level 16% 16%
High skill level 8% 8%
Retired 49% 50%
Disposable income (dKK)
Median 125,757 122,812
10th pctl 61,311 58,995
90th pctl 254,411 254,053
At least 2 prescriptions within a year (data only available since
1996)
Non-aspirin NSAID 28% 27%
Aspirin 12% 13%
Antidiabetics 4% 4%
HRT 13% 12%
Allergy medication 8% 8%
Parish level factors:
% of population with only basic education
Median 27 27
10th pctl 15 15
90th pctl 41 42
% of population in manual labor
Median 29 29
10th pctl 18 18
90th pctl 38 38
% of population retired
Median 6 6
10th pctl 3 3
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NO2, the highest risk estimates were observed for the
95-99th percentile of exposures in the categorical ana-
lysis (Table 4).
Meningioma was inversely associated with O3 (OR:
0.923, 95%CI: 0.862–0.988), which was also indicated by
the categorical analysis. For NO2 there was a positive
linear association (OR: 1.083, 95%CI: 1.016–1.154) this
was not apparent in categorical analysis. For the other
pollutants, there was no evidence of association in linear
analysis. Neither was there evidence of associations in
categorical analysis, except for the highest percentile of
PM2.5 exposure where the OR was 0.65 (95%CI: 0.43–
0.99). In linear analysis, the corresponding OR was 1.088
(95%CI: 0.955–1.239) (Table 4).
For malignant non-glioma tumors of the brain we
found an association with PM2.5 (OR: 1.267, 95%CI:
1.053–1.524 per IQR), and all PM2.5 exposure categories
above the median were associated with elevated risks
with some suggestion of exposure-response. For BC,
NO2 and NOx the corresponding ORs in the linear ana-
lyses were 1.049 (95%CI: 0.996–1.106), 1.267(95%CI:
0.983–1.194) and 1.051 (95% CI: 0.996–1.110), respect-
ively (Table 4).
There was no consistent evidence of any associations
in either the linear or the categorical analyses for sub-
groups not mentioned above (Table 4).
Adjusting for area-level covariates generally attenuated
risk estimates (Table 5). This was particularly notable
for meningioma, where all pollutants were significantly
associated in the crude and individual level adjusted
models but only the associations with NO2 and O3
remained statistically significant after additional adjust-
ment for parish level covariates. An exception from this
pattern was malignant non-glioma tumors of the brain,
for which the risk estimates increased both when includ-
ing individual and area level factors in the model.
We also analyzed air pollutant exposure averaged over
1 year and 5 years prior to diagnosis (Supplement
Table 2). For malignant tumors, there were indications
that the risk estimates were lower in association with
shorter averaging periods.
Adjusting for use of NSAIDs, HRT, antidiabetic medi-
cation and allergy medication left ORs virtually un-
changed in a sensitivity analysis of cases diagnosed after
1995 (Supplement Table 3).
Discussion
In this nationwide study, the largest to date, with more
than 20,000 intracranial CNS tumor cases, we found
PM2.5 air pollution NOx and BC to be associated with
malignant non-glioma tumors of the brain. BC and NO2
were weakly associated with increased risk for malignant
intracranial CNS tumors and O3 was inversely associated
with risk for meningioma. Total intracranial CNS tu-
mors were associated with BC air pollution in an
exposure-response manner. ORs for benign tumors were
sensitive to adjustment.
Some previous studies on air pollutants and tumors of
the brain or CNS found positive associations, whereas
others did not. When accounting for the difference of
scale, the results have confidence intervals that overlap,
indicating that they are compatible. In general, this is
also the case when comparing the present study with
previous studies (For the reader’s convenience, results
from our previous studies, rescaled to the IQR of the
present study, can be found as supplement Table 4).
In a Danish cohort, cancer of the brain was associated
with NOx (rescaled to IQR of the present study: HR
Table 1 Descriptive characteristics of intracranial CNS tumor
cases and matched controls. Denmark, 1989–2014 (Continued)
CASES CONTROLS
90th pctl 11 11
% of population unemployed
median 4 4
10th pctl 1 1
90th pctl 8 8
% of population in 1st income quartile
Median 10 10
10th pctl 5 5
90th pctl 18 18
% of population in social housing
Median 13 13
10th pctl 0 0
90th pctl 43 43
% of population owning own dwelling
Median 65 66
10th pctl 29 30
90th pctl 92 92
% single parent families
Median 5 5
10th pctl 3 3
90th pctl 7 7
% of population of Danish origin
Median 94 95
10th pctl 84 85
90th pctl 98 98
% of population previously convicted
Median 0 0
10th pctl 0 0
90th pctl 1 1
a: index date = date of diagnosis of matched case
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1.17, 95% CI: 1.04–1.31 per 18.88 μg/m3) [26]. The
present study could not confirm such an association for
the wider group of intracranial CNS tumors. The present
study, however, suggested that NO2 and BC may be as-
sociated with a small increased risk for malignant intra-
cranial CNS tumors. No other study has investigated BC
in relation to intracranial CNS tumors. However, in the
multinational ESCAPE study, the authors found suggest-
ive evidence that PM2.5 absorbance, a proxy similar to
BC, was associated with malignant CNS tumors, al-
though with a wide confidence interval spanning the null
[34]. For NO2 the HR in that study were near identical
to the ORs of the present study. A recent Canadian
study found no evidence of an association between
PM2.5 or NO2 and malignant brain tumors [23]. Turner
et al. [30] reported on malignant tumors of the brain,
adjusted for a comprehensive array of personal and area-
level confounders, and found no significant association
with PM2.5, NO2 or O3. When accounting for the differ-
ent unit scales, the HRs in that study were very similar
to those observed in our study.
In a Danish register-based investigation of tumors of
the brain, non-glioma tumors were associated with NOx
(rescaled to the IQR of the present study: OR 1.08,
95%CI: 1.004–1.169 per 18.88 μg/m3) [32]. The cases of
that study were also part of the present study, and we
found risk estimates of similar magnitude although not
statistically significant for NOx and BC. For PM2.5 we
found a stronger association.
We found inverse associations between ozone and
meningioma. We cannot provide a plausible explanation
for a causal inverse association and it could reflect the
inverse relationship between O3 and other pollutants, al-
though chance is also a possible explanation. Two previ-
ous studies, conducted on subsets of the cases in the
present study, have found some indication of associa-
tions between other air pollutants and benign brain tu-
mors. Small sample size and lack of confounder
adjustment (in one study) mean that these observations
may result from chance or confounding [32, 33].
Use of the comprehensive and virtually complete regis-
ters on the Danish population [35, 36] was a major
Table 2 Descriptive data on air pollutants among intracranial CNS tumor cases and controls in Denmark, 1989–2014
10 year time-weighted
mean exposure
min 1st pctl 5th pctl 10th pctl 25th pctl median 75th pctl 90th pctl 95th pctl 99th pctl max Inter quartile
range
BC (μg/m3)
Controls 0.29 0.37 0.43 0.47 0.55 0.72 0.94 1.21 1.49 2.42 8.00 0.39
Cases 0.29 0.38 0.43 0.47 0.56 0.73 0.94 1.21 1.50 2.43 13.64 0.38
PM2.5 (μg/m
3)
Controls 9.91 11.83 12.81 13.41 14.67 16.87 20.07 22.45 23.53 26.30 37.09 5.39
Cases 9.93 11.82 12.83 13.40 14.63 16.76 19.95 22.43 23.52 26.06 41.46 5.31
NO2 (μg/m
3)
Controls 5.68 8.12 10.35 11.79 14.57 25.35 19.18 31.06 35.72 48.33 73.86 10.78
Cases 5.66 8.20 10.39 11.85 14.79 25.60 19.35 31.22 35.74 48.26 79.00 10.81
NOx (μg/m
3)
Controls 6.13 8.84 11.42 13.17 17.06 24.83 35.92 51.01 67.33 116.69 270.31 18.86
Cases 6.15 8.93 11.48 13.26 17.34 25.15 36.35 51.35 67.22 115.37 330.91 19.01
O3 (μg/m
3)
Controls 15.82 37.5 47.04 50.70 55.58 60.92 65.30 68.44 70.26 73.81 77.45 9.72
Cases 15.72 37.05 47.08 50.63 55.43 60.78 65.12 68.38 70.33 73.56 77.68 9.69
Table 3 Pearson correlations between pollutants
10 year mean
BC (μg/m3)
10 year mean
PM2.5 (μg/m3)
10 year mean
NOX (μg/m3)
10 year mean
NO2 (μg/m3)
10 year mean
O3 (μg/m3)
Air pollutants
10 year mean O3 (μg/m3) −0.85 −0.62 −0.88 −0.98 1.00
10 year mean NO2 (μg/m3) 0.88 0.57 0.92 1.00
10 year mean NOX (μg/m
3) 0.94 0.55 1.00
10 year mean PM2.5 (μg/m
3) 0.54 1.00
10 year mean BC (μg/m3) 1.00
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Table 5 Effects of confounder adjustment on linear associations between time-weighted average air pollution (10 years before
index date) and risk of intracranial CNS tumors, Denmark 1989–2014
Air
pollutant
IQR
(μg/
m3)
Model 1a Model 2b Model 3c
OR pr IQR 95%CI OR pr IQR 95%CI OR pr IQR 95%CI
Intracranial CNS tumors (Cases: 21055 Controls: 37356)
NOx 18.86 1.020 (1.004–1.036) 1.025 (1.009–1.041) 1.011 (0.992–1.030)
NO2 10.78 1.041 (1.017–1.066) 1.052 (1.027–1.077) 1.031 (0.997–1.066)
BC 0.39 1.025 (1.008–1.042) 1.030 (1.013–1.048) 1.016 (0.996–1.037)
PM2.5 5.39 1.042 (0.981–1.107) 1.053 (0.991–1.119) 1.010 (0.944–1.080)
O3 9.72 0.957 (0.934–0.981) 0.948 (0.924–0.972) 0.967 (0.934–1.002)
Malignant (Cases: 9785 Controls: 17397)
NOx 18.86 1.025 (1.001–1.049) 1.035 (1.011–1.060) 1.026 (0.998–1.056)
NO2 10.78 1.033 (0.999–1.069) 1.051 (1.015–1.089) 1.042 (0.992–1.095)
BC 0.39 1.030 (1.006–1.056) 1.040 (1.015–1.066) 1.034 (1.005–1.065)
PM2.5 5.39 1.022 (0.936–1.116) 1.041 (0.953–1.138) 1.021 (0.926–1.126)
O3 9.72 0.968 (0.934–1.003) 0.952 (0.918–0.987) 0.962 (0.913–1.012)
Non-malignant (Cases: 11270 Controls: 19968)
NOx 18.86 1.015 (0.993–1.037) 1.017 (0.995–1.039) 0.998 (0.972–1.025)
NO2 10.78 1.048 (1.015–1.982) 1.054 (1.020–1.089) 1.022 (0.976–1.070)
BC 0.39 1.020 (0.997–1.044) 1.022 (0.998–1.046) 1.000 (0.972–1.028)
PM2.5 5.39 1.061 (0.977–1.153) 1.065 (0.980–1.158) 1.000 (0.912–1.096)
O3 9.72 0.948 (0.917–0.980) 0.943 (0.911–0.975) 0.972 (0.926–1.021)
Glioma (Cases: 7465 Controls: 13091)
NOx 18.86 1.021 (0.994–1.050) 1.034 (1.005–1.063) 1.017 (0.983–1.052)
NO2 10.78 1.031 (0.990–1.073) 1.052 (1.010–1.096) 1.026 (0.969–1.087)
BC 0.39 1.029 (1.000–1.059) 1.041 (1.011–1.071) 1.028 (0.993–1.063)
PM2.5 5.39 0.964 (0.868–1.069) 0.984 (0.886–1.093) 0.938 (0.836–1.053)
O3 9.72 0.968 (0.929–1.009) 0.949 (0.909–0.990) 0.973 (0.916–1.033)
Meningioma (Cases: 5657 Controls: 10094)
NOx 18.86 1.046 (1.014–1.078) 1.044 (1.012–1.077) 1.009 (0.972–1.047)
NO2 10.78 1.133 (1.083–1.185) 1.132 (1.082–1.185) 1.083 (1.016–1.154)
BC 0.39 1.058 (1.024–1.093) 1.056 (1.022–1.092) 1.016 (0.977–1.057)
PM2.5 5.39 1.211 (1.076–1.363) 1.202 (1.067–1.354) 1.088 (0.955–1.239)
O3 9.72 0.878 (0.837–0.920) 0.878 (0.836–0.921) 0.923 (0.862–0.988)
Cranial Nerves (Cases: 2470 Controls: 4311)
NOx 18.86 0.953 (0.903–1.005) 0.960 (0.909–1.014) 0.970 (0.908–1.036)
NO2 10.78 0.940 (0.873–1.011) 0.945 (0.877–1.019) 0.952 (0.858–1.058)
BC 0.39 0.941 (0.889–0.996) 0.946 (0.893–1.002) 0.943 (0.879–1.011)
PM2.5 5.39 0.966 (0.799–1.168) 0.969 (0.799–1.175) 0.963 (0.776–1.194)
O3 9.72 1.057 (0.979–1.141) 1.054 (0.975–1.141) 1.046 (0.936–1.169)
Malignant Non-glioma tumors of brain proper (Cases: 2301 Controls: 4247)
NOx 18.86 1.034 (0.991–1.080) 1.038 (0.994–1.084) 1.049 (0.996–1.106)
NO2 10.78 1.036 (0.969–1.107) 1.047 (0.978–1.120) 1.084 (0.983–1.194)
BC 0.39 1.035 (0.989–1.082) 1.038 (0.992–1.086) 1.051 (0.996–1.110)
PM2.5 5.39 1.179 (0.998–1.393) 1.191 (1.007–1.409) 1.267 (1.053–1.524)
O3 9.72 0.975 (0.910–1.045) 0.965 (0.899–1.035) 0.937 (0.846–1.037)
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strength of our study and allowed us to include all cases
in Denmark over a 26-year period. In addition, we were
able to investigate subgroups of CNS tumors and to
identify even weak associations. The Danish registers
provided nearly complete address histories for the vast
majority of participants. These address histories in com-
bination with a state-of-the-art air pollution model sys-
tem allowed us to estimate TWA concentration of
outdoor pollution at addresses over the ten years prior
to diagnosis, but we had no information about occupa-
tional exposures. However, previous studies found little
or no influence on risk estimates from adjustment for
occupation in the petrochemical industry [26, 34]. We
estimated exposure with a state-of-the-art integrated air
pollution system, which has shown good prediction of
both temporal and spatial variation down to the street
scale [46, 50, 51]. Even so, some non-differential expos-
ure misclassification is inevitable and may have driven
risk estimates towards the null. It is possible that our
10-year TWA metrics may not optimally capture the
relevant time window of air pollution exposure. How-
ever, for malignant tumors and for malignant non-
glioma tumors of the brain, shorter TWA-periods were
associated with lower risk estimates, suggesting that an
association is better captured by the 10 year TWA-
period. It was a major strength of our study that we in a
nationwide study, could adjust in detail for personal so-
cioeconomic position, medication use and neighborhood
socio-demographic factors. However, we cannot rule out
that confounding from unknown risk factors or chance
may have affected our findings, particularly since we per-
formed a large number of analyses. It was a potential
limitation that we did not have information on BMI, and
smoking, which some studies associated with glioma or
meningioma. We also lacked information on ionizing ra-
diation, which is an established risk factor for CNS tu-
mors. We, however, consider the potential bias small, as
we can think of no obvious route of association with air
pollution in a Danish context, beyond what is addressed
by socioeconomic covariates. A potential limitation for
the benign tumors is that we had no information on
scanning procedures prior to diagnosis. It may have af-
fected our results for benign tumors if the quality or
likelihood of scanning differed by air pollution level;
some benign tumors can be symptom free for many
years and may only be detected by chance during rou-
tine scanning [52]. We did not account for pre-existing
genetic conditions associated with risk for CNS tumors.
If families with such genetic syndromes are more likely
to live in urban or rural areas, it may have affected risk
estimates. However, the size of this potential bias is lim-
ited by the low population prevalence of such conditions
and the small proportion of CNS tumors related to such
syndromes.
The case-populations of the three previous Danish
studies [26, 32, 33], as well as parts of the multi-
national ESCAPE study [34] are nested within the
population of the present study. Similar errors or ran-
dom effects may therefore have influenced the results
of these studies, which constitute the majority of pub-
lications on residential air-pollution and CNS-tumors.
In our crude model, ORs were elevated for both be-
nign and malignant tumors. Adjustment for area-level
SES brought ORs for benign tumors close to unity
whereas the ORs for malignant tumors remained ele-
vated. Benign and malignant tumors are generally dif-
ferent diseases and may have different etiologies.
Some benign tumors may go undetected for years or
even for life. Our results indicate that the likelihood
of receiving brain scans, which could discover benign
tumors, is associated with some area level socioeco-
nomic factor that is also associated with higher levels
of air pollution. Our results for malignant tumors are
more likely to reflect true association, as these tumors
will typically be detected due to symptoms and not as
chance findings at brain scans.
Table 5 Effects of confounder adjustment on linear associations between time-weighted average air pollution (10 years before
index date) and risk of intracranial CNS tumors, Denmark 1989–2014 (Continued)
Air
pollutant
IQR
(μg/
m3)
Model 1a Model 2b Model 3c
OR pr IQR 95%CI OR pr IQR 95%CI OR pr IQR 95%CI
Non-malignant Non-glioma tumors of brain proper (Cases: 3162 Controls: 5622)
NOx 18.86 1.001 (0.964–1.040) 1.007 (0.969–1.047) 0.995 (0.950–1.042)
NO2 10.78 0.990 (0.933–1.049) 1.005 (0.947–1.067) 0.969 (0.890–1.054)
BC 0.39 1.006 (0.996–1.047) 1.013 (0.972–1.055) 1.003 (0.956–1.053)
PM2.5 5.39 0.920 (0.792–1.068) 0.947 (0.815–1.101) 0.897 (0.759–1.060)
O3 9.72 1.000 (0.941–1.064) 0.982 (0.923–1.046) 0.994 (0.920–1.073)
aCrude model, adjusted for age, sex and month of birth by matching
bModel 1 with additional adjustment individual level data on marital status, occupational status, personal income, region of origin
cModel 2 with additional adjustment for area level information on % of parish population with income in lowest quartile, unemployed, manual labor, retired, basic
education, living in social housing, owning their own dwelling, single parent families, previously convicted, of Danish origin
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On the whole, our results suggest that if any associ-
ation exists between air pollution and CNS tumors, it is
likely weak. For benign tumors, adequate confounder
control appears to be particularly important.
Conclusion
The present study is the largest study to date on air pol-
lutants and intracranial tumors of the CNS, and indi-
cates that air pollution is a risk factor for CNS tumors.
Our data suggest that, the most likely relationship is
with malignant intracranial CNS tumors and malignant
non-glioma tumors of the brain. However, additional in-
dependent studies are needed.
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